<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>International Travel Medicine Center of Iran</PublisherName>
				<JournalTitle>International Journal of Travel Medicine and Global Health</JournalTitle>
				<Issn>2322-1100</Issn>
				<Volume>13</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Macrophages type 2 as candidates for the treatment of lung injuries</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">222232</ELocationID>
			
<ELocationID EIdType="doi">10.30491/ijtmgh.2025.527814.1490</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Alireza</FirstName>
					<LastName>Shahriary</LastName>
<Affiliation>Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mostafa</FirstName>
					<LastName>Eslami Mahmoudabadi</LastName>
<Affiliation>Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Alireza</FirstName>
					<LastName>Nikkhah</LastName>
<Affiliation>Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>18</Day>
				</PubDate>
			</History>
		<Abstract>Sulfur mustard (SM) is a toxic chemical warfare agent that causes severe and persistent pulmonary damage, for which no specific treatment exists. Emerging evidence suggests that mesenchymal stem cells (MSCs) exert anti-inflammatory effects through paracrine signaling. This study evaluated the therapeutic potential of monocytes treated with MSC-derived supernatant in a murine model of SM-induced lung inflammation using CEES as a surrogate. Monocytes treated with MSC supernatant showed significant immunomodulatory effects, including reduced pro-inflammatory cytokines (IL-12), increased anti-inflammatory cytokines (IL-4, IL-10, TGF-β), and decreased oxidative stress markers (NO, MPO). Histopathological analysis revealed reduced inflammation, mucus accumulation, and tissue remodeling in treated animals. These findings suggest that MSC supernatant-treated monocytes may offer a novel therapeutic strategy for chemical-induced lung injury, warranting further investigation into their mechanisms and efficacy in more complex models.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Mustard gas</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Mesenchymal Stem Cells</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Monocyte Therapy</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijtmgh.com/article_222232_4750a0f966079c410a027e4a15aa4512.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
